← All candidates
49 insider filings on record.
49 filings on record.
COLLCOLLEGIUM PHARMACEUTICAL, INC
NasdaqGS · Healthcare · $678.88M
$21.84
-4.25% · Sep 15
49 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 8 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$678.88M
Float
30.3M
98% public
Short % float
Pro
Price / profit
17.2
Price / future profit
3.3
Price / sales
0.8
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
3 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
44 more transactions on Pro →Context
Wall St
$54.33 avg target
+148.8% vs today · 6 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
2 of 4 quarters beat
Q1 '26$1.76 act+$0.24
Q4 '25$2.04 act−$0.10
Q3 '25$2.25 act+$0.39
Q2 '25$1.68 act−$0.17
Coverage
Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock?Zacks · 07-09Collegium Pharmaceutical Stock Gains 12% in Three Months: Here's WhyZacks · 07-01Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now?Zacks · 06-232 Reasons to Sell COLL and 1 Stock to Buy InsteadStockStory · 06-03
The file stays open
49 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice